Generalized glucocorticoid resistance

Source: Wikipedia, the free encyclopedia.
(Redirected from
Glucocorticoid resistance
)
Generalized glucocorticoid resistance
Other namesChrousos syndrome
homodimer in the nucleus interacting with DNA. Right. Binding of synthetic glucocorticoid dexamethasone to ligand-binding domain of receptor in cytoplasm.
SpecialtyEndocrinology

Generalized glucocorticoid resistance or Chrousos syndrome is a rare genetic disorder that can run in families or be sporadic. It is characterized by partial or generalized target-tissue insensitivity to glucocorticoids.[1]

The clinical spectrum includes severe, potentially fatal conditions like hypoglycemia, alkalosis, or severe hypokalemia, as well as completely asymptomatic forms. The disease's most prevalent symptom is fatigue.[2]

The elevated 24-hour

hypercortisolism and the elevated serum cortisol concentrations point to the diagnosis of generalized glucocorticoid resistance.[3]

The goal of treatment for generalized glucocorticoid resistance is to reduce excessive ACTH secretion, which in turn reduces the production of more adrenal steroids that have androgenic and mineralocorticoid properties.[4] High dosages of synthetic glucocorticoids that spare mineralocorticoids, like dexamethasone, are used as part of the treatment.[5]

Signs and symptoms

Individuals who have generalized glucocorticoid resistance may exhibit biochemical

46, XX.[7]

In rare instances,

Causes

Mechanism

Steroid hormones known as "glucocorticoids" are produced in the zona fasciculata of the adrenal cortex and numerous other extra-adrenal organs, such as the skin, thymus, and gut.[11] These lipophilic molecules are essential for the maintenance of both resting as well as threatened homeostasis[12] and are secreted in the circulatory system in reaction to stressors[13] and also in an ultradian and circadian manner.[14]

Diagnosis

The elevated 24-hour

hypercortisolism and the elevated serum cortisol concentrations point to the diagnosis of generalized glucocorticoid resistance. ACTH plasma concentrations can range from low to high.[3] To confirm the diagnosis, peripheral blood mononuclear cells must be used in thymidine incorporation and dexamethasone-binding assays in conjunction with sequencing of the human glucocorticoid receptor gene.[15]

When diagnosing generalized glucocorticoid resistance, the differential diagnosis consists of additional factors that can lead to

ACTH concentrations coexist with hypercortisolism.[3]

Treatment

The goal of treatment for generalized glucocorticoid resistance is to reduce excessive

See also

References

Further reading

External links